FDA expands Mounjaro approval for heart attack and stroke prevention
The Food and Drug Administration is expanding the use of the diabetes drug Mounjaro to help prevent heart attacks and strokes in high-risk adults with type 2 diabetes.The new approval applies to the drug produced by Eli Lilly.RELATED STORY | Mounjaro or Ozempic: Which is better...











